🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China flag China · Delayed Price · Currency is CNY
26.31
-0.12 (-0.45%)
Nov 20, 2026, 3:00 PM CST

SHA:600993 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,9403,8163,6803,0983,4973,363
Other Revenue
50.4650.4648.538.335.1222.53
3,9903,8673,7283,1373,5323,385
Revenue Growth
5.75%3.72%18.85%-11.20%4.35%21.26%
Cost of Revenue
2,1281,9661,9971,8292,0382,019
Gross Profit
1,8631,9011,7311,3071,4941,366
Selling, General & Admin
1,0961,1471,051825.21886.06818.05
Research & Development
65.7778.1166.6969.0177.8966.73
Other Operating Expenses
29.5425.3517.624.3926.1625.06
Operating Expenses
1,1901,2561,144922.541,000912.9
Operating Income
672.88644.71587.12384.73494.16453.38
Interest Expense
-4.93-7.38-7.38-16.85-11.69-10.21
Interest & Investment Income
52.8570.0578.88151.598.9278.85
Currency Exchange Gain (Loss)
0.130.13-0.060.050.04-0.21
Other Non Operating Income (Expenses)
2.962.160.99-3.78-6.22-4.92
EBT Excluding Unusual Items
723.91709.68659.55515.65575.22516.89
Impairment of Goodwill
-2.28-2.28----
Gain (Loss) on Sale of Investments
0.47-5.77-6.57-0.35-38.0617.63
Gain (Loss) on Sale of Assets
-5-5.21-0.141.12-0.01-0.5
Asset Writedown
-2.19-0.01-5.25--0.34-0.44
Other Unusual Items
12.5912.599.968.2822.3314.58
Pretax Income
727.49709657.55524.7559.14548.16
Income Tax Expense
106.92103.29109.2672.8679.7874.11
Earnings From Continuing Operations
620.57605.71548.3451.84479.35474.05
Minority Interest in Earnings
-25.75-24.22-20.2-8.59-0.78-9.46
Net Income
594.83581.49528.09443.25478.57464.59
Net Income to Common
594.83581.49528.09443.25478.57464.59
Net Income Growth
4.06%10.11%19.14%-7.38%3.01%10.87%
Shares Outstanding (Basic)
429431429430431430
Shares Outstanding (Diluted)
429431429430431430
Shares Change
1.71%0.32%-0.23%-0.19%0.22%-0.43%
EPS (Basic)
1.391.351.231.031.111.08
EPS (Diluted)
1.391.351.231.031.111.08
EPS Growth
2.32%9.76%19.42%-7.21%2.78%11.34%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
690.59481.07293.76355.7266.84532.07
Free Cash Flow Per Share
1.611.120.680.830.621.24
Dividend Per Share
0.7000.7000.6200.4000.3500.350
Dividend Growth
12.90%12.90%55.00%14.29%0%16.67%
Gross Margin
46.68%49.16%46.43%41.68%42.30%40.36%
Operating Margin
16.86%16.67%15.75%12.26%13.99%13.39%
Profit Margin
14.91%15.04%14.17%14.13%13.55%13.73%
Free Cash Flow Margin
17.31%12.44%7.88%11.34%7.55%15.72%
EBITDA
737.17703.43638.41434.2541.14495.12
EBITDA Margin
18.47%18.19%17.13%13.84%15.32%14.63%
D&A For EBITDA
64.2958.7251.2949.4846.9841.74
EBIT
672.88644.71587.12384.73494.16453.38
EBIT Margin
16.86%16.67%15.75%12.26%13.99%13.39%
Effective Tax Rate
14.70%14.57%16.61%13.89%14.27%13.52%
Revenue as Reported
3,9903,8673,7283,1373,5323,385
Advertising Expenses
-222.35161.6472.5681.2559.99